Article

SARS-CoV-2 Delta Variant Predominant at a Tertiary-Care Hospital in Saudi Arabia

2021-08-06

Abstract excerpt

<title>Abstract</title> <p>Despite the effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines against SARS-CoV-2, the delta (B.1.617.2) variant of concern (VOC) has spread globally, and breakthrough infections have been reported. We identified the circulating variants and effectiveness of those vaccines between April and June 2021 at a tertiary-care hospital in Saudi Arabia. Among 320 patients with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9366001e-0ba1-50f4-8481-3272885a9a1d
DOI: 10.21203/rs.3.rs-779549/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Delta Variant Predominant at a Tertiary-Care Hospital in Saudi ArabiaDOI 10.21203/rs.3.rs-779549/v1Read

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated IndividualsSemantic proximity Read

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.Semantic proximity Read

Current Review of Delta Variant of SARS-CoV-2Semantic proximity Read

Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, TexasSemantic proximity Read

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape.Semantic proximity Read

Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape.Semantic proximity Read

SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loadsSemantic proximity Read

A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the WorldSemantic proximity Read

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in QatarSemantic proximity Read

Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough casesSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthroughSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthroughSemantic proximity Read